42 results on '"Tateyama, Masakuni"'
Search Results
2. Efficacy of a new traction method using ring-shaped thread for endoscopic submucosal dissection in the pharynx
3. Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study
4. Modified albumin–bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients
5. Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma.
6. A randomized phase I / II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma
7. Clinical usefulness of inside stents in anastomotic biliary strictures after liver transplantation.
8. Clinical usefulness of inside stents in anastomotic biliary strictures after liver transplantation
9. Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study
10. Clinical evaluation of highly sensitive iTACT hepatitis B core-related antigen and hepatitis B surface antigen assays in the management of HBV reactivation
11. Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment
12. Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma
13. Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study
14. Mixed Neuroendocrine Non-Neuroendocrine Neoplasm Arising in the Ectopic Gastric Mucosa of Esophagus
15. Efficacy of a new traction method using ring-shaped thread for endoscopic submucosal dissection in the pharynx
16. Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients
17. Comparison of endoscopic submucosal resection with ligation and endoscopic submucosal dissection for small rectal neuroendocrine tumors: A multicenter retrospective study
18. Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation
19. Comparison of endoscopic submucosal resection with ligation and endoscopic submucosal dissection for small rectal neuroendocrine tumors: A multicenter retrospective study.
20. Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B
21. Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma
22. Clinical impact of gastrointestinal endoscopy on the early detection of pharyngeal squamous cell carcinoma: A retrospective cohort study
23. Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity
24. A case of primary hepatic leiomyosarcoma treated with multi-line chemotherapy
25. A genome‐wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites
26. Serum miR-192-5p Levels Predict the Efficacy of Pegylated Interferon Therapy for Chronic Hepatitis B
27. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients
28. Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
29. A Genome-Wide Association Study Identifying SVEP1 Variant as a Predictor of Response to Tolvaptan for Cirrhotic Ascites
30. Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma.
31. WED-163 - Clinical evaluation of highly sensitive iTACT hepatitis B core-related antigen and hepatitis B surface antigen assays in the management of HBV reactivation
32. Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies
33. Oral branched-chain amino acid administration improves the structure and function of human serum albumin in patients with chronic liver diseases: 2009
34. Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: A case control study
35. Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity.
36. Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients
37. Risk factors for Hepatocellular carcinoma in hepatitis C virus-positive patients
38. Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method
39. A case of acute hepatitis B on the patient of primary biliary cirrhosis who was registered for the brain-death donor liver transplantation
40. Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
41. [A case of cholangiolocellular carcinoma combined with intrahepatic cholangiocarcinoma diagnosed after 4 years follow-up for hepatic hemangioma].
42. [A case of ectopic hepatocellular carcinoma].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.